Sharekhan's research report on SRF
Q3 result was weak with a 12% miss in the consolidated PAT at Rs. 253 crore (down 16% q-o-q) due to continued headwinds of inventory rationalization for specialty chemical, pricing led margin pressure for ref-gas and challenging environment for packaging films. Chemical/packaging film/technical textile EBIT declined by 7%/42%/8% q-o-q to Rs. 322 crore/Rs. 45 crore/Rs. 69 crore in Q3FY24. Management indicated that Q4FY24 to be better as it has witnessed significant recovery in specialty chemical, expect ref-gas price to be more rational and sees traction in new molecules. SRF commissioned PTFE, HFC expansion, Aluminium foil facility and guided for capex of Rs. 2,000-2,200 crore for FY25.
Outlook
We maintain our Buy on SRF with an unchanged PT of Rs. 2,745. SRF is a quality player and its investment in specialty chemicals provides strong long-term earnings growth prospects. Valuation seems reasonable at 24x its FY2026E EPS.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.